CT SB01202 | 2023 | General Assembly

Status

Spectrum: Committee Bill
Status: Introduced on March 9 2023 - 25% progression, died in committee
Action: 2023-03-21 - Joint Favorable Change of Reference Insurance and Real Estate
Pending: Joint Insurance and Real Estate Committee
Text: Latest bill text (Introduced) [PDF]

Summary

To (1) require that certain prescription drugs purchased in the state not exceed upper payment limits set by Medicare pursuant to the federal Inflation Reduction Act, (2) establish a Prescription Drug Payment Evaluation Committee to recommend upper payment limits on not less than eight drugs based on such limits in other states or countries, and (3) require the Office of Health Strategy to monitor and make public the costliest prescription drugs.

Tracking Information

Register now for our free OneVote public service or GAITS Pro trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

An Act Concerning Prescription Drug Affordability.

Sponsors


Roll Calls

2023-03-21 - Joint - HS Vote Tally Sheet (Joint Favorable Change of Reference) (Y: 21 N: 0 NV: 0 Abs: 0) [PASS]
2023-03-21 - Joint - HS Vote Tally Sheet (MOTION FAILED) (Y: 21 N: 0 NV: 0 Abs: 0) [PASS]
2023-03-21 - Joint - HS Vote Tally Sheet (Joint Favorable Change of Reference) (Y: 21 N: 0 NV: 0 Abs: 0) [PASS]

History

DateChamberAction
2023-03-21SenateJoint Favorable Change of Reference Insurance and Real Estate
2023-03-10SenatePublic Hearing 03/16
2023-03-09SenateReferred to Joint Committee on Human Services

Connecticut State Sources


Bill Comments

feedback